APA Alıntı

Lucasti, C., Hershberger, E., Miller, B., Yankelev, S., Steenbergen, J., Friedland, I., & Solomkin, J. (2014). Multicenter, Double-Blind, Randomized, Phase II Trial To Assess the Safety and Efficacy of Ceftolozane-Tazobactam plus Metronidazole Compared with Meropenem in Adult Patients with Complicated Intra-Abdominal Infections. American Society for Microbiology.

Chicago Stili Alıntı

Lucasti, Christopher, Ellie Hershberger, Benjamin Miller, Sara Yankelev, Judith Steenbergen, Ian Friedland, ve Joseph Solomkin. Multicenter, Double-Blind, Randomized, Phase II Trial To Assess the Safety and Efficacy of Ceftolozane-Tazobactam Plus Metronidazole Compared With Meropenem in Adult Patients With Complicated Intra-Abdominal Infections. American Society for Microbiology, 2014.

MLA Alıntı

Lucasti, Christopher, et al. Multicenter, Double-Blind, Randomized, Phase II Trial To Assess the Safety and Efficacy of Ceftolozane-Tazobactam Plus Metronidazole Compared With Meropenem in Adult Patients With Complicated Intra-Abdominal Infections. American Society for Microbiology, 2014.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..